🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/05/2003 | 56,17 | 56,76 | 56,07 | 56,61 | +0,56% | 1,22% | 4.648.928 |
| 12/05/2003 | 55,56 | 56,39 | 55,11 | 56,30 | +1,32% | 2,30% | 5.045.491 |
| 09/05/2003 | 55,80 | 56,13 | 55,40 | 55,56 | +0,05% | 1,30% | 4.667.687 |
| 08/05/2003 | 55,88 | 55,92 | 55,27 | 55,53 | -0,60% | 1,16% | 4.242.409 |
| 07/05/2003 | 56,20 | 56,44 | 55,57 | 55,87 | -0,59% | 1,54% | 5.473.704 |
| 06/05/2003 | 56,26 | 56,39 | 55,73 | 56,20 | -0,10% | 1,17% | 5.053.666 |
| 05/05/2003 | 56,39 | 56,73 | 55,80 | 56,26 | -0,56% | 1,64% | 4.112.457 |
| 02/05/2003 | 55,15 | 56,97 | 55,15 | 56,57 | +1,35% | 3,29% | 5.753.730 |
| 01/05/2003 | 55,52 | 56,11 | 54,61 | 55,82 | +0,55% | 2,70% | 4.815.246 |
| 30/04/2003 | 54,96 | 56,09 | 54,73 | 55,52 | +1,43% | 2,47% | 9.990.374 |
| 29/04/2003 | 54,48 | 55,11 | 54,10 | 54,73 | +0,28% | 1,86% | 4.678.062 |
| 28/04/2003 | 54,06 | 54,91 | 53,48 | 54,58 | +0,79% | 2,65% | 5.643.690 |
| 25/04/2003 | 55,49 | 55,55 | 53,65 | 54,15 | -2,66% | 3,44% | 7.165.071 |
| 24/04/2003 | 54,93 | 56,13 | 54,82 | 55,63 | +0,28% | 2,38% | 6.733.714 |
| 23/04/2003 | 56,34 | 56,82 | 55,17 | 55,48 | -1,27% | 2,93% | 11.430.746 |
| 22/04/2003 | 54,82 | 56,59 | 54,74 | 56,19 | +3,39% | 3,38% | 10.347.009 |
| 21/04/2003 | 53,72 | 55,30 | 53,72 | 54,35 | +1,91% | 2,93% | 7.212.860 |
| 17/04/2003 | 53,54 | 53,82 | 52,63 | 53,33 | -0,39% | 2,21% | 6.480.413 |
| 16/04/2003 | 54,48 | 54,57 | 53,44 | 53,54 | -1,44% | 2,08% | 5.493.616 |
| 15/04/2003 | 54,06 | 54,44 | 53,77 | 54,32 | +0,46% | 1,24% | 4.734.130 |
| 14/04/2003 | 52,88 | 54,10 | 52,86 | 54,07 | +2,26% | 2,35% | 4.117.802 |
| 11/04/2003 | 53,51 | 54,05 | 52,78 | 52,88 | -0,52% | 2,37% | 4.598.729 |
| 10/04/2003 | 53,10 | 53,21 | 52,15 | 53,16 | +0,11% | 1,99% | 5.525.790 |
| 09/04/2003 | 54,11 | 54,48 | 52,96 | 53,10 | -1,87% | 2,82% | 5.401.078 |
| 08/04/2003 | 54,22 | 54,77 | 53,91 | 54,11 | -0,21% | 1,58% | 4.888.082 |
| 07/04/2003 | 55,25 | 55,77 | 54,15 | 54,23 | -0,65% | 2,94% | 5.805.920 |
| 04/04/2003 | 53,58 | 54,87 | 53,55 | 54,58 | +1,94% | 2,46% | 5.647.043 |
| 03/04/2003 | 54,17 | 54,17 | 53,39 | 53,54 | -1,16% | 1,44% | 7.892.802 |
| 02/04/2003 | 53,05 | 54,65 | 53,05 | 54,17 | +2,10% | 3,00% | 5.443.522 |
| 01/04/2003 | 52,58 | 53,24 | 52,27 | 53,05 | +1,50% | 1,85% | 5.316.399 |